Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
OraSure to Present at J.P Morgan Healthcare Conference
Recludix Pharma to Present at the Annual J.P. Morgan Healthcare Conference
Recludix Pharma, a leader in the discovery of inhibitors of challenging targets for inflammatory disease, today announced that Nancy Whiting, Pharm.D., president and chief executive officer of Recludix,
J.P. Morgan increases security for 2025 conference
The J.P. Morgan Healthcare Conference attracts thousands of attendees each year from the provider, insurance, digital health and pharmaceutical sectors.
ADARx Pharmaceuticals to Present at the J.P. Morgan 43ʳᵈ Annual Healthcare Conference
About ADARx Pharmaceuticals ADARx Pharmaceuticals, Inc. is a late-stage clinical biotechnology company dedicated to transforming cutting-edge science into next-generation RNA medicines across a wide range of therapeutic areas.
2h
on MSN
eVTOL stocks are on watch after J.P. Morgan warns hype may be flying too high
J.P. Morgan turned cautious on the eVTOL sector as it attempted to balance the near-term relativeshare price outperformance ...
Commercial Observer
2d
JP Morgan to Order Staff to Return to Offices Five Days a Week
J.P. Morgan Chase, with about 300,000 employees worldwide, is expected to announce the end of hybrid and remote work in the ...
Institutional Investor
2d
J.P. Morgan’s Michael Cembalest Predicts Trump “Alchemists” Will Prompt a Correction in 2025
J.P. Morgan Asset Management’s Michael Cembalest calls them “Alchemists” — the Trump White House nominees who are looking to ...
3d
on MSN
This J.P. Morgan Analyst Is Upbeat About Google. The Stock Is Up.
J.P. Morgan analyst Doug Anmuth said he sees room for Alphabet, Google’s parent, to gain ground on a variety of fronts, ...
BioSpace
1d
Biopharma Finishes 2024 Strong With ‘Robust’ VC, Upfront Payments: JP Morgan
J.P. Morgan releases its quarterly look-ahead days before the entire biopharma industry descends on San Francisco for the ...
Modern Healthcare
6h
JPM 2025: What's slated for the San Francisco conference
More than 8,000 healthcare professionals will descend on San Francisco starting Monday for the 43rd annual J.P. Morgan ...
1d
J.P. Morgan Sticks to Its Buy Rating for Constellation Energy Corporation (CEG)
In a report released on January 7, Jeremy Tonet from J.P. Morgan maintained a Buy rating on Constellation Energy Corporation (CEG – Research ...
3h
Alyea Therapeutics to Present at Biotech Showcase 2025 During 43rd Annual J.P. Morgan Healthcare Conference Week
LAS VEGAS, NV / ACCESSWIRE / / Alyea Therapeutics Corporation Inc. ("Alyea" or the "Company"), a subsidiary of Alt 5 Sigma Corporation (NASDAQ:ALTS), announced today its engagement in key events ...
2d
on MSN
Ultrapar upgraded at J.P. Morgan, citing strategic resilience and growth
In Ultragaz, the company has been strengthening its presence in the bulk market with associated solutions and better margins, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback